DEA Rules on Doctor's Fate in Routine Order
Published Date: 12/22/2025
Notice
Summary
Dr. David Halvorson from Alabama lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of October 31, 2025. This means he can’t prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Halvorson
The DEA revoked David Halvorson, M.D.'s Certificate of Registration No. BH3453278 and denied any pending applications to renew, modify, or obtain additional registration in Alabama. The Order is effective January 21, 2026; the record also shows his Alabama medical license was revoked on or about June 6, 2025 and his DEA registration expired on October 31, 2025.
DEA Policy: State Authority Required
Under 21 U.S.C. 824(a)(3) and long-standing DEA precedent cited in this Order, the DEA will revoke a practitioner's federal controlled-substances registration if the practitioner no longer has state authority to dispense controlled substances (for example, after a state license suspension or revocation). The Order reiterates that possession of state authority to dispense controlled substances is a fundamental condition for obtaining and maintaining a DEA practitioner registration.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05482 — Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
If you order Schedule I or II drugs using DEA Form 222, this update clears up who can sign and manage the form—only registrants, their partners, or officers can do it. It also removes old rules about the old triplicate form, making things simpler and clearer. These fixes don’t change any big rules and take effect on March 20, 2026, so no extra costs or hassles ahead!
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
2026-05359 — Importer of Controlled Substances Application: United States Pharmacopeial Convention
The United States Pharmacopeial Convention wants to become an official importer of certain controlled substances like Cathinone and Methcathinone. If you’re a registered manufacturer or interested party, you have until April 20, 2026, to share your thoughts or ask for a hearing. This move could impact how these substances are imported and tracked, but no direct costs are mentioned.
Previous / Next Documents
Previous: 2025-23544 — Notice of Inventory Completion: Florida Department of State, Tallahassee, FL
The Florida Department of State has finished checking some Native American human remains and found they belong to the Pueblo of Jemez tribe. Starting January 21, 2026, these remains can be returned to the tribe. This is part of a respectful effort to give back important cultural items and remains to Native communities.
Next: 2025-23546 — Submission for Office of Management and Budget Review; Proposed Information Collection Activity; Office of Community Services Community Economic Development Performance Progress Report
The Office of Community Services is updating how community economic development grant recipients report their progress. New awardees will now submit shorter reports every quarter, while others stick to twice a year. This change helps keep projects on track and improves how the government supports and tracks job creation and spending, with comments due by January 21, 2026.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in